ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,223Medicare Part D Prescriptions Filled, Including Refills
$862K Total Retail Price of All Prescriptions
192 Patients Receiving at Least One Drug in Part D
29%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
METHADONE HCL 1,189 222 S2
HYDROCODONE-ACETAMINOPHEN 578 187 S3
OXYCODONE HCL 370 36 S2
ENDOCET 367 60 S2
LAMOTRIGINE 302 25
CRESTOR 255 56
ALLOPURINOL 251 43
METFORMIN HCL ER 201 65
CITALOPRAM HBR 174 30
MORPHINE SULFATE ER 172 100 S2
OMEPRAZOLE 162 22
ZOLPIDEM TARTRATE 149 40
CHLORTHALIDONE 145 33
RISPERIDONE 144 0
POTASSIUM CHLORIDE 143 41
JANUVIA 134 42
OXYCODONE HCL-ACETAMINOPHEN 132 59 S2
PROMETHAZINE HCL 124 17 R
ZETIA 124 17
ESCITALOPRAM OXALATE 106 12
ABILIFY 101 20
ATORVASTATIN CALCIUM 97 31
LYRICA 97 19
PRISTIQ ER 96 16
NEXIUM 94 0
FUROSEMIDE 90 34
POLYETHYLENE GLYCOL 3350 89 17
CARVEDILOL 85 21
TIZANIDINE HCL 84 13
GABAPENTIN 84 16
AMLODIPINE BESYLATE 80 36
ROPINIROLE HCL 67 17
LISINOPRIL 65 0
TESTOSTERONE CYPIONATE 63 0 S3
SINGULAIR 61 0
LEXAPRO 61 11
METFORMIN HCL 52 34
AVODART 52 23
NATEGLINIDE 51 12
SYNTHROID 51 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.